Status:
COMPLETED
Vitamin D Supplementation for Bipolar Depression
Lead Sponsor:
University of Massachusetts, Worcester
Conditions:
Bipolar Disorder
Bipolar Depression
Eligibility:
All Genders
18-75 years
Phase:
NA
Brief Summary
The purpose of this study is to whether vitamin d supplementation in those with low levels may reduce depression symptoms in people experiencing bipolar depression.
Eligibility Criteria
Inclusion
- Adults \>18years old
- Bipolar disorder (I,II or NOS),
- MADRS Score\>7 (mild),
- 25(OH)D level \<30ng/ml (insufficient).
- able to take the prescribed vitamin D by mouth
Exclusion
- Systemic diseases such as:
- liver and kidney diseases,
- known parathyroid disorder,
- disorders of vitamin D metabolism,
- taking vitamin D replacement therapy,
- fat digestion disorder,
- diabetes mellitus,
- gi surgery
- If the serum calcium in the range 2.50-2.55 mmol L, inclusion required a serum PTH below 5.0 pmol L-acute psychiatric urgency:
- active suicidality,
- acute psychosis,
- active substance use\<6mo or
- pregnant or nursing females
Key Trial Info
Start Date :
June 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 1 2015
Estimated Enrollment :
33 Patients enrolled
Trial Details
Trial ID
NCT01884844
Start Date
June 1 2013
End Date
August 1 2015
Last Update
June 19 2018
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Massachusettes
Worcester, Massachusetts, United States, 01604
2
University of Massachusetts School of Medicine
Worcester, Massachusetts, United States, 01605